EP3923918A4 - Compositions de sel d'acide mixte de bêta-hydroxybutyrate et procédés d'utilisation - Google Patents

Compositions de sel d'acide mixte de bêta-hydroxybutyrate et procédés d'utilisation Download PDF

Info

Publication number
EP3923918A4
EP3923918A4 EP20755770.3A EP20755770A EP3923918A4 EP 3923918 A4 EP3923918 A4 EP 3923918A4 EP 20755770 A EP20755770 A EP 20755770A EP 3923918 A4 EP3923918 A4 EP 3923918A4
Authority
EP
European Patent Office
Prior art keywords
beta
methods
acid compositions
mixed salt
hydroxybutyrate mixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20755770.3A
Other languages
German (de)
English (en)
Other versions
EP3923918A1 (fr
Inventor
Gary MILLET
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Access Global Sciences LLC
Original Assignee
Access Global Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/272,145 external-priority patent/US10736861B2/en
Application filed by Access Global Sciences LLC filed Critical Access Global Sciences LLC
Publication of EP3923918A1 publication Critical patent/EP3923918A1/fr
Publication of EP3923918A4 publication Critical patent/EP3923918A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP20755770.3A 2019-02-11 2020-02-06 Compositions de sel d'acide mixte de bêta-hydroxybutyrate et procédés d'utilisation Pending EP3923918A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/272,145 US10736861B2 (en) 2016-03-11 2019-02-11 Mixed salt compositions for producing elevated and sustained ketosis
US16/720,211 US11020362B2 (en) 2016-03-11 2019-12-19 Beta-hydroxybutyrate mixed salt compositions and methods of use
PCT/US2020/016952 WO2020167571A1 (fr) 2019-02-11 2020-02-06 Compositions de sel d'acide mixte de bêta-hydroxybutyrate et procédés d'utilisation

Publications (2)

Publication Number Publication Date
EP3923918A1 EP3923918A1 (fr) 2021-12-22
EP3923918A4 true EP3923918A4 (fr) 2022-10-05

Family

ID=72045290

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20755770.3A Pending EP3923918A4 (fr) 2019-02-11 2020-02-06 Compositions de sel d'acide mixte de bêta-hydroxybutyrate et procédés d'utilisation

Country Status (6)

Country Link
EP (1) EP3923918A4 (fr)
JP (2) JP2022520560A (fr)
CN (1) CN113660930A (fr)
AU (1) AU2020221031A1 (fr)
CA (1) CA3129411A1 (fr)
WO (1) WO2020167571A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112262936A (zh) * 2020-10-22 2021-01-26 珠海麦得发生物科技股份有限公司 一种含3-羟基丁酸的饮品及其制备方法和应用
CN115251375A (zh) * 2022-07-11 2022-11-01 珠海麦得发生物科技股份有限公司 一种(r)-3-羟基丁酸生酮产品及其制备方法
WO2024067626A1 (fr) * 2022-09-27 2024-04-04 南京纽邦生物科技有限公司 Composite d'acide et de sel, et son procédé de préparation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170258745A1 (en) * 2016-03-11 2017-09-14 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003219796A1 (en) * 2002-02-20 2003-09-09 Beth Israel Deaconess Medical Center Conjugates comprising a biodegradable polymer and uses therefor
CN101678043A (zh) * 2007-03-30 2010-03-24 有限会社爱泽世 生酮作用促进剂组合物
CN101969769A (zh) * 2008-01-04 2011-02-09 伊希斯创新有限公司 用作降低血脂药剂的酮体和酮体酯
MX371259B (es) * 2013-03-19 2020-01-23 Univ South Florida Composiciones y métodos para producir cetosis elevada y sostenida.
WO2017184788A1 (fr) * 2016-04-19 2017-10-26 Keto Patent Group, Inc. Administration de butyrate, de bêta-hydroxybutyrate et de composés apparentés à des humains
US10588877B2 (en) * 2016-07-21 2020-03-17 Savind, Inc. Compositions comprising β-hydroxybutyric acid and salt, and methods of using the same
US20180057846A1 (en) * 2016-08-30 2018-03-01 KetoneAid Inc. Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
WO2018187852A1 (fr) * 2017-04-12 2018-10-18 Cavaleri Franco Compositions de butyrate et bêta-hydroxybutyrate et leurs procédés d'utilisation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170258745A1 (en) * 2016-03-11 2017-09-14 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis

Also Published As

Publication number Publication date
AU2020221031A1 (en) 2021-09-02
CA3129411A1 (fr) 2020-08-20
JP2022520560A (ja) 2022-03-31
JP2023166029A (ja) 2023-11-17
WO2020167571A1 (fr) 2020-08-20
CN113660930A (zh) 2021-11-16
EP3923918A1 (fr) 2021-12-22

Similar Documents

Publication Publication Date Title
EP4022059A4 (fr) Compositions d'oligonucléotides et leurs procédés d'utilisation
EP3959318A4 (fr) Compositions d'oligonucléotides et leurs méthodes d'utilisation
EP3965780A4 (fr) Compositions oligonucléotidiques et leurs procédés d'utilisation
EP3923925A4 (fr) Compositions de sel-acide mixtes de bêta-hydroxybutyrate racémique et procédés d'utilisation
EP3843720A4 (fr) Compositions d'inhibiteurs de cxcr4 et méthodes de préparation et d'utilisation
EP3962296A4 (fr) Compositions de cannabinoïdes et procédés d'utilisation
EP3923918A4 (fr) Compositions de sel d'acide mixte de bêta-hydroxybutyrate et procédés d'utilisation
EP3893917A4 (fr) Compositions d'il-15 et leurs procédés d'utilisation
EP3761972A4 (fr) Compositions bioréactives et leurs procédés d'utilisation
EP3749343A4 (fr) Formulation et procédé d'utilisation
EP3684369A4 (fr) Compositions d'anticorps a33 et leurs méthodes d'utilisation en radioimmunothérapie
EP3829307A4 (fr) Compositions de bismuth-thiol et méthodes d'utilisation
IL291622A (en) Compositions comprising regulatory t cells and methods of making and using them
EP3917543A4 (fr) Compositions de nitrate améliorées et procédés d'utilisation
EP3856214A4 (fr) Compositions microbiennes et méthodes d'utilisation
EP3768677A4 (fr) Compositions d'activateurs de canal kv7 et procédés d'utilisation
EP3677126A4 (fr) Composition d'inhibiteurs d'age, son utilisation, son procédé de préparation et sa formulation
EP3934426A4 (fr) Compositions de conservation et leurs procédés d'utilisation
EP3840769A4 (fr) Compositions de cyclosporine et méthodes d'utilisation
EP4045226A4 (fr) Compositions de polissage et leurs procédés d'utilisation
EP3941909A4 (fr) Inhibiteurs de pi4-kinase et leurs procédés d'utilisation
EP3774708A4 (fr) Compositions à base d'un inhibiteur de foxm1 et procédés d'utilisation correspondantes
EP3843555A4 (fr) Compositions de colorant à base d'anthocyane et leurs procédés d'utilisation
EP4054514A4 (fr) Compositions contenant des fenchols et procédés d'utilisation
EP4028023A4 (fr) Compositions comprenant des molécules d'arn modifié et leurs méthodes d'utilisation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210825

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220901

RIC1 Information provided on ipc code assigned before grant

Ipc: A23L 33/12 20160101ALI20220826BHEP

Ipc: A61P 3/00 20060101ALI20220826BHEP

Ipc: A61K 45/06 20060101ALI20220826BHEP

Ipc: A61K 31/593 20060101ALI20220826BHEP

Ipc: A61K 31/19 20060101ALI20220826BHEP

Ipc: A61K 31/12 20060101AFI20220826BHEP